Skip to content

Short- and Long-term HRV Measurements After Osteopathic Myofascial Thoracic Manipulations

Études Des Effets d'un Protocol de thérapie Manuelle ostéopathique Sur la variabilité de la fréquence Cardiaque

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04234958
Enrollment
162
Registered
2020-01-21
Start date
2017-03-15
Completion date
2018-01-17
Last updated
2020-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Rate Variability

Keywords

heart rate variability, autonomous nervous system, osteopathy, osteopathy manipulative treatment, visceral, pericardium

Brief summary

The adaptation of the heart to react to any stimulus is called heart rate variability (HRV). Moreover, HRV is now used as a health index. In fact, among the pathologies affecting HRV the most, there are the cardiovascular diseases and depressive disorders that take a predominant part in the investigator's actual societies, According to a recent literature overview, many factors influence HRV and they need to be determined in order to plan efficient research protocols. Moreover, the control of these factors can improve the HRV and therefore help the heart to have maximum capacity to fulfill its physiological functions. Valorizing a good HRV seems, according to the effects reported by several studies, to be a good opportunity to take into consideration and to apply. Visceral osteopathy, even if it goes back to the founder of Osteopathy himself, Andrew Taylor Still, is at its debuts in terms of acknowledgement from a scientific point of view. The evidence of efficacy of osteopathy is not to be done anymore. However, it is now necessary to define the action mechanisms of the osteopathic techniques, particularly by using physiological variables, and starting from a biomechanical angle. In fact, Jean-Pierre Barral and others has developed visceral manipulation techniques based on the viscera anatomy. The originality of this research can be found in the technical protocol, not used yet, the use of witness group, the measurements over four weeks to evaluate the effect of this protocol with time on chosen dependant variables, its reproducibility but also its inter-therapist variance. This objective if this study is to reinforce the proof level of the osteopathic approach on the cardiac physiology. HRV is a solid tool recognized for research, the variable is well isolated and the control group ensures an isolation of some confounding variables.

Interventions

OTHEROsteopathic manipulative treatment

Specific protocol including 4 osteopathic techniques targeting the pericardium

OTHERSham therapy

Sham therapy mimicking the osteopathic techniques applied to experimental group

Sponsors

Collège d'Études Ostéopathiques de Montreal
CollaboratorUNKNOWN
Université du Québec a Montréal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Intervention model description

randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
25 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* man or woman * between 25 and 35 years old * healthy * non smoking

Exclusion criteria

* diagnosed with anxiety or psychological disorder * smoker, drug consumption * diagnosed with renal disorder, cardiac disorder, functional somatic disorders, diabetes, chronic alcoholism, cancer or immunosuppressive disorders, stroke, aortic aneurysm, * pregnant * high level athletes * thoracic trauma or surgeries * does not fit Hexoskin vest for HRV measurements * does not complete all sessions * cannot stay lying down for 1 hour * below 25 or above 35 years old * student in manual therapy

Design outcomes

Primary

MeasureTime frameDescription
Heart rate variability45 minutesReal-time measurements of HRV before, during and after each intervention

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026